{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T04:34:47Z","timestamp":1778646887041,"version":"3.51.4"},"reference-count":62,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T00:00:00Z","timestamp":1750723200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Hepatic fibrosis and the fatty liver index (FLI) are critical indicators for assessing the progression and severity of metabolic dysfunction-associated steatotic liver disease (MASLD) and serve as valuable reference markers for predicting MASLD-related risks. The Dietary Inflammation Index (DII) quantifies the inflammatory effects of dietary intake and has been extensively utilized in nutritional and epidemiological studies. Although studies have been conducted to confirm the correlation between dietary quality and MASLD in the general population, this study sought to further explore the association between the DII and key indicators of liver disease severity\u2014namely hepatic fibrosis and the FLI\u2014within a cohort diagnosed with MASLD. In addition, the potential mediating role of the systemic immune inflammatory index (SII) in these associations was also investigated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This cross-sectional study was based on data from the 2017\u20132020 cycles of the U.S. National Health and Nutrition Examination Survey (NHANES), a nationally representative program designed to assess the health and nutritional status of the population. In this study, we analyzed the correlation of DII with FLI and liver fibrosis in a population of patients with MASLD by linear regression, logistic regression, RCS curves and subgroup analysis. A mediation model was applied to assess the potential intermediary effect of SII on the associations between DII, FLI, and hepatic fibrosis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The results of this study indicate that, after adjusting for all covariates, the Dietary Inflammatory Index (DII) was not significantly associated with the Fatty Liver Index (FLI) among U.S. adults with MASLD (\u03b2 = 0.32, 95% CI: \u22121.393 to 2.034, <jats:italic>P<\/jats:italic> = 0.631). Similarly, no significant association was observed between DII and the risk of liver fibrosis (OR = 1.152, 95% CI: 0.885 to 1.499, <jats:italic>P<\/jats:italic> = 0.210). Subgroup analyses further demonstrated that these associations were not modified by demographic or metabolic stratification variables, and the relationship appeared to be nonlinear.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>In U.S. adults with MASLD, no significant association was found between DII and the risk of liver fibrosis or elevated FLI. Although DII is linked to various chronic diseases, its role in MASLD appears limited and non-specific, particularly in capturing intermittent disease progression. No mediating effect of SII was observed. These findings underscore the importance of carefully considering dietary factors in the clinical evaluation of MASLD progression. The potential relationship between diet and liver disease progression warrants further investigation.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fnut.2025.1594192","type":"journal-article","created":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T14:59:46Z","timestamp":1750777186000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Association of dietary inflammatory index with liver fibrosis and fatty liver index in a population with metabolic dysfunction-associated steatotic liver disease: A cross-sectional study"],"prefix":"10.3389","volume":"12","author":[{"given":"Ziqi","family":"Sang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Leng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xupeng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruolin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiejun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Houbo","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J Hepatol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J Hepatol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/s41575-023-00846-4","article-title":"Recompensation in cirrhosis: unravelling the evolving natural history of nonalcoholic fatty liver disease","volume":"21","author":"Feng","year":"2024","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1097\/CRD.0000000000000932","article-title":"Metabolic dysfunction-associated steatotic liver disease as a cardiovascular risk factor: focus on atrial fibrillation","author":"Awashra","year":"2025","journal-title":"Cardiol Rev."},{"key":"B5","doi-asserted-by":"publisher","first-page":"101898","DOI":"10.1016\/j.aohep.2025.101898","article-title":"Global burden and future trends of metabolic dysfunction-associated steatotic liver disease: 1990\u20132021 to 2045","volume":"30","author":"Kan","year":"2025","journal-title":"Ann Hepatol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1016\/j.cgh.2024.03.006","article-title":"The global epidemiology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among patients with type 2 diabetes","volume":"22","author":"Younossi","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"774079","DOI":"10.3389\/fmed.2021.774079","article-title":"MAFLD\/NAFLD biopsy-free scoring systems for hepatic steatosis, NASH, and fibrosis diagnosis","volume":"8","author":"Segura-Azuara","year":"2022","journal-title":"Front Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1016\/j.jhep.2022.06.012","article-title":"Immune mechanisms linking metabolic injury to inflammation and fibrosis in fatty liver disease \u2013 novel insights into cellular communication circuits","volume":"77","author":"Peiseler","year":"2022","journal-title":"J Hepatol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1340453","DOI":"10.3389\/fnut.2024.1340453","article-title":"Dietary inflammatory index is associated with metabolic dysfunction-associated fatty liver disease among United States adults","volume":"11","author":"Yan","year":"2024","journal-title":"Front Nutr."},{"key":"B10","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.dld.2023.09.024","article-title":"Association between dietary inflammatory index and risk of fatty liver disease: a systematic review and meta-analysis","volume":"56","author":"Zhao","year":"2024","journal-title":"Dig Liver Dis."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1080\/00365521.2024.2395851","article-title":"Anti-inflammatory diet reduces risk of metabolic dysfunction-associated fatty liver disease among US adults: a nationwide survey","volume":"59","author":"Hu","year":"2024","journal-title":"Scand J Gastroenterol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1446694","DOI":"10.3389\/fnut.2024.1446694","article-title":"Associations of five dietary indices with metabolic dysfunction-associated steatotic liver disease and liver fibrosis among the United States population","volume":"11","author":"Xu","year":"2024","journal-title":"Front Nutr."},{"key":"B13","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1093\/advances\/nmz087","article-title":"Comment on \u201cperspective: the dietary inflammatory index (dii)-lessons learned, improvements made, and future directions","volume":"11","author":"van Duijnhoven","year":"2020"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1111\/jgh.15363","article-title":"Relationship between dietary patterns and non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"36","author":"Hassani Zadeh","year":"2021","journal-title":"J Gastroenterol Hepatol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s12876-024-03585-1","article-title":"Dietary inflammatory index and its association with fatty liver disease: a study in obese and non-obese populations","volume":"25","author":"Fu","year":"2025","journal-title":"BMC Gastroenterol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1417840","DOI":"10.3389\/fendo.2024.1417840","article-title":"The relationship between dietary inflammatory index and all-cause and cardiovascular disease-related mortality in adults with metabolic syndrome: a cohort study of NHANES","volume":"15","author":"Ma","year":"2025","journal-title":"Front Endocrinol (Lausanne)."},{"key":"B17","doi-asserted-by":"publisher","first-page":"781567","DOI":"10.3389\/fmed.2021.781567","article-title":"Inflammation and fibrogenesis in MAFLD: role of the hepatic immune system","volume":"8","author":"Torre","year":"2021","journal-title":"Front Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s12944-023-01947-4","article-title":"Shift in prevalence and systemic inflammation levels from NAFLD to MAFLD: a population-based cross-sectional study","volume":"22","author":"Liu","year":"2023","journal-title":"Lipids Health Dis."},{"key":"B19","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1007\/s13105-023-00954-4","article-title":"de la Torre Al\u00e1ez M, Sangro B, D'Avola D. Metabolic dysfunction-associated fatty liver disease (MAFLD): an update of the recent advances in pharmacological treatment","volume":"79","author":"Sangro","year":"2023","journal-title":"J Physiol Biochem."},{"key":"B20","doi-asserted-by":"publisher","first-page":"761538","DOI":"10.3389\/fmed.2021.761538","article-title":"Liver fibrosis and MAFLD: from molecular aspects to novel pharmacological strategies","volume":"8","author":"Qu","year":"2021","journal-title":"Front Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"e2146705","DOI":"10.1001\/jamanetworkopen.2021.46705","article-title":"Evaluation of the quality of evidence of the association of foods and nutrients with cardiovascular disease and diabetes: a systematic review","volume":"5","author":"Miller","year":"2022","journal-title":"JAMA Netw Open."},{"key":"B22","doi-asserted-by":"publisher","first-page":"4135","DOI":"10.3390\/ijerph17114135","article-title":"Chronic inflammation in the context of everyday life: dietary changes as mitigating factors","volume":"17","author":"Margin\u0103","year":"2020","journal-title":"Int J Environ Res Public Health."},{"key":"B23","doi-asserted-by":"publisher","first-page":"4595","DOI":"10.2147\/JIR.S509814","article-title":"Dynamic status of systemic immune inflammation index is associated with metabolic dysfunction-associated steatotic liver disease: an evidence from a ten-year prospective longitudinal cohort study","volume":"18","author":"He","year":"2025","journal-title":"J Inflamm Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"e0321251","DOI":"10.1371\/journal.pone.0321251","article-title":"Exploring the association between dietary indices and metabolic dysfunction-associated steatotic liver disease: mediation analysis and evidence from NHANES","volume":"20","author":"Wang","year":"2025","journal-title":"PLoS One."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1478165","DOI":"10.3389\/fnut.2025.1478165","article-title":"Association of dietary inflammatory index on all-cause and cardiovascular mortality in U. S adults with metabolic dysfunction associated steatotic liver disease","volume":"12","author":"Tao","year":"2025","journal-title":"Front Nutr."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1534604","DOI":"10.3389\/fnut.2025.1534604","article-title":"Adherence to the planetary health diet index and metabolic dysfunction-associated steatotic liver disease: a cross-sectional study","volume":"12","author":"Qiu","year":"2025","journal-title":"Front Nutr."},{"key":"B27","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","article-title":"EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"81","year":"2024","journal-title":"J Hepatol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S2468-1253(20)30357-5","article-title":"Shalimar, Voican CS, Thiele M, et al. Assessment of hepatic steatosis by controlled attenuation parameter using the M and XL probes: an individual patient data meta-analysis","volume":"6","author":"Petroff","year":"2021","journal-title":"Lancet Gastroenterol Hepatol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jhep.2021.10.008","article-title":"Reply to: correspondence on \u201cEASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis \u2013 2021 update\u201d","volume":"76","year":"2022","journal-title":"J Hepatol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1016\/j.jhep.2022.03.026","article-title":"Impact of non-invasive biomarkers on hepatology practice: past, present and future","volume":"76","author":"Anstee","year":"2022","journal-title":"J Hepatol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1544917","DOI":"10.3389\/fimmu.2025.1544917","article-title":"Association of high-sensitivity C-reactive protein with hepatic fibrosis in patients with metabolic dysfunction-associated steatotic liver disease","volume":"16","author":"Wu","year":"2025","journal-title":"Front Immunol."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-025-11533-0","article-title":"Concordance of vibration-controlled transient elastography and magnetic resonance elastography for fibrosis staging in patients with metabolic dysfunction-associated steatotic liver disease","author":"Mathur","year":"2025","journal-title":"Eur Radiol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1002\/oby.21483","article-title":"Fatty liver index is a risk determinant of incident type 2 diabetes in a metabolically healthy population with obesity","volume":"24","author":"Jung","year":"2016","journal-title":"Obesity."},{"key":"B34","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s12944-023-01924-x","article-title":"Correction: a cross-sectional study exploring the relationship between the dietary inflammatory index and hyperlipidemia based on the National Health and Nutrition Examination Survey (2005\u20132018)","volume":"22","author":"Han","year":"2023","journal-title":"Lipids Health Dis."},{"key":"B35","doi-asserted-by":"publisher","first-page":"e13349","DOI":"10.1111\/obr.13349","article-title":"The dietary inflammatory index, obesity, type 2 diabetes, and cardiovascular risk factors and diseases","volume":"23","author":"Hariharan","year":"2022","journal-title":"Obes Rev."},{"key":"B36","doi-asserted-by":"publisher","first-page":"4553","DOI":"10.3390\/nu15214553","article-title":"Construct validation of the dietary inflammatory index (DII) among young college-aged women","volume":"15","author":"Azarmanesh","year":"2023","journal-title":"Nutrients."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.3390\/nu15081857","article-title":"The relationship between the dietary inflammatory index (DII) and metabolic syndrome (MetS) in middle-aged and elderly individuals in the United States","volume":"15","author":"Zhao","year":"2023","journal-title":"Nutrients."},{"key":"B38","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3390\/nu15010219","article-title":"Association between dietary inflammatory index and sarcopenia: a meta-analysis","volume":"15","author":"Diao","year":"2023","journal-title":"Nutrients."},{"key":"B39","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1186\/s12876-024-03538-8","article-title":"The moderating effect of dietary fiber intake on the association between sleep pattern and liver fibrosis in metabolic dysfunction-associated steatotic liver disease: a study from NHANES","volume":"24","author":"Jia","year":"2024","journal-title":"BMC Gastroenterol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1334506","DOI":"10.3389\/fnut.2024.1334506","article-title":"The relationship between dietary inflammatory index and metabolic syndrome and its components: a case study in Kashi urban, Xinjiang","volume":"11","author":"Zhang","year":"2024","journal-title":"Front Nutr."},{"key":"B41","doi-asserted-by":"publisher","first-page":"4505","DOI":"10.3390\/nu14214505","article-title":"Dietary quality and relationships with metabolic dysfunction-associated fatty liver disease (MAFLD) among United States adults, results from NHANES 2017\u20132018","volume":"14","author":"Tian","year":"2022","journal-title":"Nutrients."},{"key":"B42","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.clnesp.2024.11.032","article-title":"Dietary inflammatory potential and metabolic (dysfunction)-associated steatotic liver disease and its complications: a comprehensive review","volume":"65","author":"Sepehrinia","year":"2025","journal-title":"Clin Nutr ESPEN."},{"key":"B43","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1097\/MCG.0000000000002079","article-title":"Exploring biomarkers in nonalcoholic fatty liver disease among individuals with type 2 diabetes mellitus","volume":"59","author":"Ahmadizar","year":"2025","journal-title":"J Clin Gastroenterol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.ypmed.2017.03.016","article-title":"Malecki KM. The association of dietary inflammatory potential with depression and mental well-being among US adults","volume":"99","author":"Bergmans","year":"2017","journal-title":"Prev Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"4162","DOI":"10.3390\/nu13114162","article-title":"Association between diet quality indices and incidence of type 2 diabetes in the Melbourne collaborative cohort study","volume":"13","author":"Hodge","year":"2021","journal-title":"Nutrients."},{"key":"B46","doi-asserted-by":"publisher","first-page":"106400","DOI":"10.1016\/j.prostaglandins.2019.106400","article-title":"Cytochrome P450-derived eicosanoids and inflammation in liver diseases","volume":"147","author":"Shoieb","year":"2020","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"B47","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1002\/hep4.1453","article-title":"Icosabutate exerts beneficial effects upon insulin sensitivity, hepatic inflammation, lipotoxicity, and fibrosis in mice","volume":"4","author":"van den Hoek","year":"2019","journal-title":"Hepatol Commun."},{"key":"B48","doi-asserted-by":"publisher","first-page":"6969","DOI":"10.3390\/ijms22136969","article-title":"Fructose and the liver","volume":"22","author":"Muriel","year":"2021","journal-title":"Int J Mol Sci."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.3390\/nu13041314","article-title":"The role of fructose in non-alcoholic steatohepatitis: old relationship and new insights","volume":"13","author":"Federico","year":"2021","journal-title":"Nutrients."},{"key":"B50","doi-asserted-by":"publisher","first-page":"365","DOI":"10.3390\/biomedicines9040365","article-title":"Tveden-Nyborg P. Hepatic stellate cell activation and inactivation in NASH-fibrosis\u2014roles as putative treatment targets?","volume":"9","author":"Zisser","year":"2021","journal-title":"Biomedicines."},{"key":"B51","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/s41575-023-00832-w","article-title":"Cellular stress in the pathogenesis of nonalcoholic steatohepatitis and liver fibrosis","volume":"20","author":"Sharma","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2025.03.010","article-title":"Regulation of hepatic stellate cell phenotypes in metabolic dysfunction-associated steatohepatitis","author":"Kisseleva","year":"2025","journal-title":"Gastroenterology."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.3390\/biology12121471","article-title":"Targeting the adipose tissue\u2013liver\u2013gut microbiota crosstalk to cure MASLD","volume":"12","author":"Gabbia","year":"2023","journal-title":"Biology."},{"key":"B54","doi-asserted-by":"publisher","first-page":"5640","DOI":"10.3390\/ijms25115640","article-title":"Metabolic dysfunction-associated steatotic liver disease: from pathogenesis to current therapeutic options","volume":"25","author":"Portincasa","year":"2024","journal-title":"Int J Mol Sci."},{"key":"B55","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3390\/nu17010143","article-title":"Dietary influences on gut microbiota and their role in metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"17","author":"Hamamah","year":"2024","journal-title":"Nutrients."},{"key":"B56","doi-asserted-by":"publisher","first-page":"30","DOI":"10.31083\/j.fbl2901030","article-title":"Autophagy, ferroptosis, apoptosis and pyroptosis in metabolic dysfunction-associated steatotic liver disease","volume":"29","author":"Zhao","year":"2024","journal-title":"Front Biosci."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.3390\/biomedicines12081653","article-title":"Remnant pancreas volume affects new-onset impaired glucose homeostasis secondary to pancreatic cancer","volume":"12","author":"Yang","year":"2024","journal-title":"Biomedicines."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.3390\/jcm14061809","article-title":"Chronic obstructive pulmonary disease and type 2 diabetes mellitus: complex interactions and clinical implications","volume":"14","author":"Anghel","year":"2025","journal-title":"J Clin Med."},{"key":"B59","doi-asserted-by":"publisher","first-page":"455","DOI":"10.3390\/livers4030033","article-title":"Understanding macrophage complexity in metabolic dysfunction-associated steatotic liver disease: transitioning from the M1\/M2 paradigm to spatial dynamics","volume":"4","author":"Ahamed","year":"2024","journal-title":"Livers."},{"key":"B60","doi-asserted-by":"publisher","first-page":"155952","DOI":"10.1016\/j.metabol.2024.155952","article-title":"The lipopolysaccharide-TLR4 axis regulates hepatic glutaminase 1 expression promoting liver ammonia build-up as steatotic liver disease progresses to steatohepatitis","volume":"158","author":"Mercado-G\u00f3mez","year":"2024","journal-title":"Metabolism."},{"key":"B61","doi-asserted-by":"publisher","first-page":"RP100731","DOI":"10.7554\/eLife.100731","article-title":"A host enzyme reduces metabolic dysfunction-associated steatotic liver disease (MASLD) by inactivating intestinal lipopolysaccharide","volume":"13","author":"Wang","year":"2025","journal-title":"Elife."},{"key":"B62","doi-asserted-by":"publisher","first-page":"3448","DOI":"10.3390\/ijms26073448","article-title":"Hidden in the fat: unpacking the metabolic tango between metabolic dysfunction-associated steatotic liver disease and metabolic syndrome","volume":"26","author":"Boulos","year":"2025","journal-title":"Int J Mol Sci."}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2025.1594192\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T14:59:46Z","timestamp":1750777186000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2025.1594192\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,24]]},"references-count":62,"alternative-id":["10.3389\/fnut.2025.1594192"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2025.1594192","relation":{},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,24]]},"article-number":"1594192"}}